A New York federal judge on Friday ordered Martin Shkreli to pay nearly $65 million and banned the disgraced former executive from ever working in the pharmaceutical industry again, siding with Attorney General Letitia James in a high-profile lawsuit stemming from his move to dramatically raise the price of a life-saving drug in 2015.

U.S. District Judge Denise L. Cote said in a 135-page opinion that Shkreli, whose exploits once gave him the derogatory moniker “Pharma Bro,” violated state and federal laws in exerting monopoly power over Daraprim, which is used to treat parasitic infections and HIV.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]